Exact Mass: 441.0583710000001

Aristolactam Ia N-beta-glucoside

Aristolactam Ia N-beta-D-glucopyranoside

Glucomatronalin

3,4-dihydroxybenzyl glucosinolate

C14H19NO11S2 (441.0399504)

10-(beta-D-glucopyranosyloxy)-benzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-5(6H)-one|aristololactam IIIa 6-(beta-D-glucopyranoside)|manshurienine A

C20H16BrN3O2S (441.01465360000003)

(+)-(6S)-discorhabdine S|discorhabdin S

O1-(6-sulfanilylamino-[3]pyridyl)-beta-D-glucopyranuronic acid|O1-(6-Sulfanilylamino-[3]pyridyl)-beta-D-glucopyranuronsaeure

C17H19N3O9S (441.0841964)

secoadociaquinone B

C18H20ClN3O6S (441.0761290000001)

9-chloro-10b,11-dihydroxy-7,8-dimethoxy-2-methyl-3-methylene-11a-methylsulfanyl-2,3,6,10b,11,11a-hexahydro-5aH-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4-dione|Sporidesmin F

secoadociaquinone A

8-(beta-D-glucopyranosyloxy)-benzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-5(6H)-one|aristolactam Ia 8-beta-D-glucoside|aristololactam Ia 8-(beta-D-glucopyranoside)|manshurienine B

C24H18ClF2NO3 (441.0943212000001)

GW848687X

Cys Cys Cys Asn

(2S)-2-[(2R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

Cys Cys Asn Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

Cys Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

Asn Cys Cys Cys

(2R)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C24H18ClF2NO3 (441.0943212000001)

5-Hydroxysulfapyridine glucuronide

C17H19N3O9S (441.0841964)

GW 848687X

6-[2-[5-chloro-2-[(2,4-digluorophenyl)methoxy]phenyl]-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid

3-Desethenyl-3-methyl Cefixime

C15H15N5O7S2 (441.041288)

sodium 3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonate

C16H12N5NaO7S (441.0355122)

4-(3-(3-nitrophenylcarbamoyl) phenylsulfonamido) benzoic acid

C20H15N3O7S (441.06306800000004)

[(η2-1,2-Ethynediyl)bis[trimethylsilane]](1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O′) copper

C13H20CuF6O2Si2 (441.0201962)

Toltrazuril sulfoxide

C18H14F3N3O5S (441.0606230000001)

ethyl 5-[4-[(4-bromo-5-methyl-1H-pyrrole-2-carbonyl)amino]piperidin-1-yl]-1,3,4-thiadiazole-2-carboxylate

C16H20BrN5O3S (441.0470150000001)

acid orange 74

C16H12N5NaO7S (441.0355122)

sodium p-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate

C16H12N5NaO7S (441.0355122)

Brimonidine tartrate

Brimonidine L-tartrate

C15H16BrN5O6 (441.0283896)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Brimonidine tartrate (UK 14304 tartrate) is a full α2-adrenergic receptor (α2-AR) agonist.

D & C Red no. 31

C23H23NO4S2 (441.10684380000004)

2,4,6-Tris(4-Carboxyphenyl)-1,3,5-Triazine

C24H15N3O6 (441.096081)

N-{3-[(2-chloro-4-pyrimidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide

C18H11ClF3N3O3S (441.0161722)

[C3MIm]TfS

C9H17F6N3O6S2 (441.0462934)

midazolam maleate

C22H17ClFN3O4 (441.08915640000004)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

Danirixin

C19H21ClFN3O4S (441.0925268000001)

C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist

N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxyphenyl)methylamino]benzenesulfonamide

C21H19N3O4S2 (441.08169340000006)

ML355 is a potent and selective inhibitor of 12-Lipoxygenase (12-LOX) with an IC50 of 0.34 μM, shows excellent selectivity over related lipoxygenases and cyclooxygenases, and possesses favorable ADME properties.

Tizoxanide glucuronide

C16H15N3O10S (441.047813)

3-[[[3-[(3-Nitrophenyl)sulfamoyl]phenyl]-oxomethyl]amino]benzoic acid

C20H15N3O7S (441.06306800000004)

Phosphomethylphosphonic acid guanosyl ester

C11H17N5O10P2 (441.0450642)

5-Chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-YL)benzamido) cyclopentyl)thiophene-2-carboxamide

C22H20ClN3O3S (441.09138400000006)

2-[3-Hydroxy-2-[(5-phenyl-1,2-oxazole-3-carbonyl)amino]phenyl]-1,3-benzoxazole-4-carboxylic acid

C24H15N3O6 (441.096081)

GDP dianion

C10H13N5O11P2-2 (441.00868080000004)

COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

2-[3-[(4-Azanyl-2-methoxy-pyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-5-yl]ethyl phosphono hydrogen phosphate

C12H19N4O8P2S+ (441.0398814)

S-(4-nitrobenzyl)-glutatione

C17H21N4O8S- (441.1080046)

Methyl 2-[[8-(furan-2-yl)-4,4-dimethyl-5-oxa-11-thia-9,14,16-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-yl]sulfanyl]acetate

C21H19N3O4S2 (441.08169340000006)

3-[5-[(Z)-(5-imino-7-oxo-3-phenyl-6-thiazolo[3,2-a]pyrimidinylidene)methyl]-2-furanyl]benzoic acid

C24H15N3O4S (441.07832300000007)

3-[2-[(E)-2-cyano-2-(4-fluorophenyl)sulfonylethenyl]pyrrol-1-yl]sulfonylbenzonitrile

C20H12FN3O4S2 (441.02532440000004)

ethyl 4-{5-[(E)-{2-[(5-bromopyridin-3-yl)carbonyl]hydrazinylidene}methyl]furan-2-yl}benzoate

C20H16BrN3O4 (441.03241160000005)

4-Oxo-3-phenyl-1-phthalazinecarboxylic acid [2-[(1,1-dioxo-3-thiolanyl)amino]-2-oxoethyl] ester

C21H19N3O6S (441.0994514000001)

Malonyl-4-phosphopantetheine

C14H22N2O10PS-3 (441.07327420000007)

1-[(4-chlorophenyl)methyl]-4-[4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-yl]-5-imino-2H-pyrrol-3-ol

C22H20ClN3O3S (441.09138400000006)

5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxybutanedioic acid

C15H16BrN5O6 (441.0283896)

(3R)-3-isocyanylbutanoyl-AMP

C15H18N6O8P- (441.09236980000003)

5-(3-Bromophenyl)-1-(furan-2-ylmethyl)-4-(5-methylfuran-2-carbonyl)pyrrolidine-2,3-dione

C21H16BrNO5 (441.02117860000004)

GDP(2-)

C10H13N5O11P2 (441.00868080000004)

An organophosphate oxoanion arising from deprotonation of two of the the three diphosphate OH groups of guanosine 5-diphosphate.

2-{[(1s)-1-methyl-5,8,12-trioxo-14-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁶,²⁰]icosa-2,4(9),6,10,13(20),15-hexaen-7-yl]amino}ethanesulfonic acid

14-hydroxy-10-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one

14-hydroxy-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one

3,4-methylenedioxy-10-hydroxy aristololactam-n-beta-d-glucoside

3,4-methylenedioxy-10-hydroxyaristololactam-n-β-d-glucoside

C19H17Cl2NO7 (441.03820320000005)

{"Ingredient_id": "HBIN007494","Ingredient_name": "3,4-methylenedioxy-10-hydroxy aristololactam-n-beta-d-glucoside","Alias": "3,4-methylenedioxy-10-hydroxyaristololactam-n-\u03b2-d-glucoside","Ingredient_formula": "C22H19NO9","Ingredient_Smile": "C1OC2=C(O1)C3=C4C=C(C=CC4=CC5=C3C(=C2)C(=O)N5C6C(C(C(C(O6)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31607;14363","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2,6-dichloro-5-hydroxy-8-methyl-1-[(1r,4r,5s,6s)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]chromeno[2,3-b]pyrrol-4-one

2,6-dichloro-5-hydroxy-8-methyl-1-[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]chromeno[2,3-b]pyrrol-4-one

C19H17Cl2NO7 (441.03820320000005)

(1s)-3-bromo-10'-methyl-6-(methylsulfanyl)-6',10',15'-triazaspiro[cyclohexane-1,3'-tetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadecane]-1'(15'),2,2'(7'),4',5,9'(16'),11'-heptaene-4,8'-dione

C20H16BrN3O2S (441.01465360000003)

(2s,3r,4s,5s,6r)-2-({9-hydroxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-14-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

16-hydroxy-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one

[(e)-[2-(3,4-dihydroxyphenyl)-1-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxysulfonic acid

C14H19NO11S2 (441.0399504)

16-hydroxy-10-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one

C20H16BrN3O2S (441.01465360000003)

(1s)-3-bromo-10'-methyl-6-(methylsulfanyl)-6',10',15'-triazaspiro[cyclohexane-1,3'-tetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadecane]-1'(15'),2,2'(7'),5,9'(16'),11',13'-heptaene-4,8'-dione

2-{[(1s)-1-methyl-5,8,12-trioxo-14-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁶,²⁰]icosa-2,4(9),6,10,13(20),15-hexaen-6-yl]amino}ethanesulfonic acid